[HTML][HTML] SARS-CoV-2 and Therapeutic Approaches

D Chugh, M Bishnoi - The Open COVID Journal, 2022 - opencovidjournal.com
Abstract In 2019, the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) was
first reported in Wuhan, China, affecting the population all over the globe. This ongoing …

[PDF][PDF] Exploiting SARS-CoV-2 Replication Cycle for COVID-19 Therapies

II Al-Janabi - Al-Rafidain Journal of Medical Sciences (ISSN 2789 …, 2021 - iasj.net
The tail end of 2019 saw the identification of SARS-CoV-2 as the causative virus of COVID-
19, which was followed in March 2020 by the assignment of pandemic status to this disease …

[HTML][HTML] Исследование потенциала препаратов на основе экстрактов лекарственных растений в отношении подавления репликации SARS-CoV-2: пилотное …

МЛД Пеллегрин, А Рорхофер, Ф Шустер… - Consilium …, 2021 - cyberleninka.ru
Актуальность. Лекарственные средства растительного происхождения давно и
успешно применяются в лечении самых разных заболеваний, в том числе и вирусной …

[PDF][PDF] CURRENT UPDATES ON THERAPEUTIC AND VACCINE APPROACHES FOR COVID-19

S Altaf, H Muzaffar - VETERINARY PATHOBIOLOGY & PUBLIC …, 2021 - researchgate.net
Several infectious viruses are rapidly emerging and evolving for the last two decades,
because of their rapid mechanism of mutation (Zolnikova et al. 2018). The viruses …

[PDF][PDF] Predicción de las cavidades medicables de la proteína S del SARS-CoV-2

A Torres Hatem - 2022 - repositorio.cinvestav.mx
Coronaviruses represent global health threat. In this century, they have already caused two
epidemics and one serious pandemic. In 2019, the appearance of SARS-CoV-2 virus that …

[HTML][HTML] Aspectos clínicos de importancia en pacientes sospechosos o confirmados con COVID-19 hospitalizados. Centro Médico Docente la Trinidad: Revisión de …

S Golfetto Miskiewicz, A Medina Ferrari… - Revista Científica …, 2022 - ve.scielo.org
El objetivo del presente trabajo fue describir las características clínicas de los pacientes con
sospecha o confirmación de COVID-19 hospitalizados en el Centro Médico Docente La …

[PDF][PDF] Mrinmoy Nag, Poushali Boral, Poulomi Biswas, Debajit Dewan, Nabanita Pramanick, Utkalika Sarkar, Souvik Chattopadhyay, and Soumya Datta, A Spotlight on …

S Biswas, D Roy, B Debnath, A Das, R Nath - Int. J. Life Sci. Pharma Res - researchgate.net
Deadly COVID-19 viruses have raised a pandemic situation in the year 2019, causing
serious and contagious respiratory infections in humans. SARS-CoV-2 (Severe Acute …

The potential of herbal extracts to inhibit SARS-CoV-2: a pilot study

R Anette, S Philipp, B Schmidt, P Philipp… - Clinical …, 2021 - search.proquest.com
Background Herbal medicinal products have a long-standing history of use in the therapy of
common respiratory infections. We sought to assess the potential of five validated herbal …

Hipopotasemia como biomarcador de gravedad en pacientes hospitalizados por covid-19 en el Hospital Essalud II–Cajamarca, en el periodo julio 2020–octubre …

DA Muñoz Goicochea - 2022 - 190.116.36.86
Objetivo: Determinar si la hipopotasemia es biomarcador de gravedad en los pacientes
hospitalizados por Covid-19. Métodos: Es un estudio de tipo observacional analítico y de …

A study of the potential of medicinalplant extracts in suppression of SARS-CoV-2 replication: a pilot study

ML De Pellegrin, A Rohrhofer, P Schuster… - Consilium …, 2021 - consilium.orscience.ru
Relevance. Medicinal products of plant origin have long been successfully used in the
treatment of various diseases, including those of viral etiology. Nevertheless, their effect on …